Cover Image

Consequences of the Updated Hemodynamic Criteria for the Classification of Chronic Thromboembolic Pulmonary Disease

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Coen van Kan, Laura Hardy, Niki Stok, Azar Kianzad, Esther Nossent, Jurjan Aman, Lilian Meijboom, Rozenn Quarck, Marion Delcroix, Harm Jan Bogaard, Anton Vonk Noordegraaf, Josien van Es
Format:	Artículo Open Access
Published:	Wiley 2026
Subjects:	Pulmonary Circulation
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Patients with CTEPH and mild hemodynamic severity of disease improve to a similar level of exercise capacity after pulmonary endarterectomy compared to patients with severe hemodynamic disease
by: Coen van Kan, et al.
Published: (2024)

Endothelial Features Along the Pulmonary Vascular Tree in Chronic Thromboembolic Pulmonary Hypertension: Distinctive or Shared Facets?
by: Janne Verhaegen, et al.
Published: (2025)

Circulating Pin1 Levels in Patients With Chronic Thromboembolic Pulmonary Hypertension: A Case‐Control Study
by: Lynn Willems, et al.
Published: (2025)

Chronic Thromboembolic Pulmonary Disease Phenotypes Using Upright Invasive Cardiopulmonary Exercise Testing
by: Pradhab Kirupaharan, et al.
Published: (2026)

Stress Echocardiography to Detect Exercise Pulmonary Hypertension in Patients With Chronic Thromboembolic Pulmonary Disease
by: Adam Dhayyat, et al.
Published: (2026)

Impact of Preoperative Hemodynamic Values on Development of Reperfusion Edema After Pulmonary Endarterectomy
by: Carolin Torregroza, et al.
Published: (2026)

Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension in an Adolescent With a Novel Frameshift Variant in PROS1
by: Hiroyuki Fujii, et al.
Published: (2026)

Hemodynamic‐Driven Staging of Heart Failure With Preserved Ejection Fraction Using Unsupervised Cluster Analysis
by: Sergio Caravita, et al.
Published: (2026)

Hemodynamic Patterns in Interstitial Lung Disease: A Snapshot of Clinical Practice and a Roadmap for Future Trials
by: Ho Cheol Kim, et al.
Published: (2025)

Hemodynamic response to inhaled nitric oxide in patients with pulmonary hypertension and chronic kidney disease: A retrospective cohort study
by: Kathryn T. del Valle, et al.
Published: (2024)

Survival and Hemodynamic Effects of Parenteral Prostanoids in High‐Altitude Group 1 Pulmonary Hypertension: A Retrospective Cohort Study
by: Rafael Conde-Camacho, et al.
Published: (2026)

Transmembrane Protein 100 Expression on Endothelial Cells Vascularizing Thrombi in Chronic Thromboembolic Pulmonary Hypertension Modulates TGFβ1−ALK1 Signaling During Angiogenesis
by: Magdalena L. Bochenek, et al.
Published: (2026)

Differences in Pulmonary Artery Flow Hemodynamics Between PAH and PH‐HFpEF: Insights From 4D‐Flow CMR
by: Bong‐Joon Kim, et al.
Published: (2025)

Association of Estimated Plasma Volume Status With Invasive Hemodynamics and Adverse Clinical Outcomes in Patients With Pulmonary Hypertension and Chronic Kidney Disease
by: Andrew Geller, et al.
Published: (2025)

Hemodynamic markers independent of pulmonary capillary wedge pressure can discriminate between pre and postcapillary exercise‐induced pulmonary hypertension
by: Margaret Montovano, et al.
Published: (2024)

Long‐Term Treatment With Subcutaneous Treprostinil in Patients With Severe Inoperable Chronic Thromboembolic Pulmonary Hypertension in the Multimodal Therapy Era (Data From CTREPH Study Open Label Extension)
by: Pavel Jansa, et al.
Published: (2025)

Revised Precapillary Pulmonary Hypertension Criteria and Their Prognostic Value in IPF Transplant Waitlist Survival
by: Zehra Dhanani, et al.
Published: (2025)

Severe pulmonary hypertension due to combined pulmonary fibrosis and emphysema: another cause of death among smokers
by: André Carramenha de Góes Hirano
Published: (2017)

Optimizing Medical Pretreatment for Balloon Pulmonary Angioplasty: Overshoot or Stride Toward Optimal Multimodal Treatment
by: D. P. Staal, et al.
Published: (2025)

Inoperable chronic thromboembolic pulmonary hypertension: Evolution of prognosis over 10 years of new emerging therapies
by: Diederik P. Staal, et al.
Published: (2024)

Precision Medicine for Pulmonary Vascular Disease: The Future Is Now (2023 Grover Conference Series)
by: Lindsay M. Forbes, et al.
Published: (2025)

Sotatercept in TBX4 Associated Heritable Pulmonary Arterial Hypertension: A Case Report of a Super Responder
by: Jop W. Schneijdenberg, et al.
Published: (2026)

Diabetic Ketoacidosis and Thromboembolic Disease in Type 1 Diabetes: A Series of 5 Cases
by: Gorgi K, et al.
Published: (2025)

INFECTED PULMONARY INFARCTION CASE REPORT
by: Laura Marcela Velásquez Gaviria
Published: (2017)

Diagnostic Accuracy of the Malnutrition Universal Screening Tool and Mini Nutritional Assessment Short‐Form in Outpatients With Pulmonary Hypertension
by: E. Grimbergen, et al.
Published: (2025)

Peripheral pulmonary artery aneurysm presenting as a solitary pulmonary nodule
by: Mauro Federico Luis Tamagno
Published: (2015)

Intimal sarcoma of the pulmonary artery presenting as pulmonary embolism
by: María Camila Plata
Published: (2017)

Impact of general anesthesia on the echocardiographic assessment of right ventricular function in pediatric patients with pulmonary arterial hypertension
by: Charles T. Simpkin, et al.
Published: (2024)

Exploring Providers' Behaviors, Attitudes, and Preferences on the Treatment of Pulmonary Arterial Hypertension With Endothelin Receptor Antagonist (ERA) + Phosphodiesterase‐5 Inhibitors (PDE5i)
by: Nicholas A. Kolaitis, et al.
Published: (2025)

Vancomycin Monitoring for Treatment of Acute Pulmonary Exacerbations of Adult Cystic Fibrosis Patients
by: Darrell Smith, et al.
Published: (2025)

Highly Effective Modulator Therapy in Cystic Fibrosis: Addressing Unusual Variants in the Middle East
by: Said Isse, et al.
Published: (2025)

Impact of selexipag maintenance dose on persistence, adherence, and hospitalization in US patients with pulmonary arterial hypertension
by: Charles D. Burger, et al.
Published: (2024)

Comment on: “Echocardiography‐Derived Exercise Pulmonary Hypertension and Longitudinal Changes in Pulmonary Artery Pressures in Systemic Sclerosis”
by: Alexandra Mihai
Published: (2026)

Alterations in ECG and Right Heart Catheterization Data in PAH Patients Who Died From Sudden Death Compared With Right Heart Failure
by: Alexandra B. Flemington, et al.
Published: (2025)

Pulmonary Artery Stent Implantation for Fibrosing Mediastinitis: Our Clinical Experience
by: Cheng Hong, et al.
Published: (2025)

Scoping review of post‐TB pulmonary vascular disease: Proceedings from the 2nd International Post‐Tuberculosis Symposium
by: Elizabeth H. Louw, et al.
Published: (2024)

Pulmonary hypertension in the setting of interstitial lung disease: Approach to management and treatment. A consensus statement from the Pulmonary Vascular Research Institute's Innovative Drug Development Initiative—Group 3 Pulmonary Hypertension
by: Oksana A. Shlobin, et al.
Published: (2024)

Exploring the Impact of Platelet‐Derived Growth Factor D in Pulmonary Hypertension Development
by: Philip Tannenberg, et al.
Published: (2025)

Rethinking Operability in Large VSD: The Diastolic Pulmonary Shunt Index (DiPSI) and a Probabilistic Perspective
by: Saurabh Kumar Gupta, et al.
Published: (2025)

Pulmonary Vascular Compromise Is Associated With Survival in Pediatric Pulmonary Hypertension: A New Computational Model
by: Maria Niccum, et al.
Published: (2025)